Botulinum Neurotoxin Treatment Dynamics and Persistence Over 2 Years in Patients With Cervical Dystonia or Spasticity: A Retrospective Claims Database Analysis

被引：0
|
作者：
Simpson, David M. [1 ]
Bouchard, Jonathan [2 ]
Page, Simon [3 ]
Spurden, Dean [3 ]
Goldfarb, Seth [2 ]
Patel, Atul T. [4 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Neurol, 1 Gustave L Levy Pl, New York, NY 10029 USA
[2] Ipsen, Cambridge, MA USA
[3] Ipsen, Slough, Berks, England
[4] Kansas City Bone & Joint Clin, Overland Pk, KS USA
来源：
TOXICON | 2024年 / 237卷
关键词：
Botulinumtoxin (BoNT); Cervical dystonia; Pediatric spasticity; Adult spasticity; Treatment dynamics; Treatment persistence;
D O I：
10.1016/j.toxicon.2024.107489
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：80 / 81
页数：3
相关论文
共 50 条
  • [1] Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache Payment policy perspectives
    Govindarajan, Raghav
    Shepard, Katie M.
    Moschonas, Constantine
    Chen, Jack J.
    NEUROLOGY-CLINICAL PRACTICE, 2016, 6 (03) : 281 - 286
  • [2] BOTULINUM TOXIN UTILIZATION AND TREATMENT COST IN ADULT AND PEDIATRIC PATIENTS WITH SPASTICITY OR CERVICAL DYSTONIA IN THE US: ADMINISTRATIVE HEALTHCARE CLAIMS DATA
    Hull, M.
    Anupindi, R.
    He, J.
    Danchenko, N.
    DeKoven, M.
    Bouchard, J. R.
    VALUE IN HEALTH, 2021, 24 : S146 - S146
  • [3] Multimodal physiotherapy as an add-on treatment to botulinum neurotoxin therapy in patients with cervical dystonia
    Werner, C.
    Derlien, S.
    Witte, O. W.
    Guenther, A.
    Smolenski, U. C.
    JOURNAL OF NEURAL TRANSMISSION, 2016, 123 (12) : 1524 - 1525
  • [4] Incidence of Dysphagia and Comorbidities in Patients With Cervical Dystonia, Analyzed by Botulinum Neurotoxin Treatment Exposure
    Sadeghi, Marjan
    Ukah, Ahunna
    Yue, Emma Xiaomeng
    Ifantides, Kim Becker
    Huang, Nuo-Yu
    Lee, Joan
    Barbano, Richard L.
    TOXICON, 2024, 237 : 75 - 77
  • [5] Incidence of Dysphagia and Comorbidities in Patients with Cervical Dystonia, Analyzed by Botulinum Neurotoxin Treatment Exposure
    Sadeghi, M.
    Ukah, A.
    Yue, E.
    Ifantides, K. Becker
    Huang, N.
    Lee, J.
    Barbano, R.
    MOVEMENT DISORDERS, 2023, 38 : S351 - S352
  • [6] Incidence of Dysphagia and Comorbidities in Patients with Cervical Dystonia, Analyzed by Botulinum Neurotoxin Treatment Exposure
    Barbano, Richard L.
    Jabbari, Bahman
    Sadeghi, Marjan
    Ukah, Ahunna
    Yue, Emma
    Ifantides, Kimberly Becker
    Huang, Nuo-Yu
    Swope, David
    TOXINS, 2025, 17 (03)
  • [7] Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US
    Hull, Michael
    Anupindi, Vamshi Ruthwik
    DeKoven, Mitchell
    He, Jing
    Bouchard, Jonathan
    ADVANCES IN THERAPY, 2023, 40 (09) : 3986 - 4003
  • [8] Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US
    Michael Hull
    Vamshi Ruthwik Anupindi
    Mitchell DeKoven
    Jing He
    Jonathan Bouchard
    Advances in Therapy, 2023, 40 : 3986 - 4003
  • [9] HOW SATISFIED ARE CERVICAL DYSTONIA PATIENTS AFTER 3 YEARS OF BOTULINUM TOXIN TREATMENT?
    Colosimo, Carlo
    Misra, Vijay P.
    Charles, David
    Chung, Tae Mo
    Maisonobe, Pascal
    Om, Savary
    TOXICON, 2018, 156 : S17 - S18
  • [10] TWSTRS scores in cervical dystonia patients previously treated with botulinum neurotoxin A (BoNT-A) versus those naive to treatment
    Trosch, R.
    Misra, P.
    Maisonobe, P.
    Om, S.
    MOVEMENT DISORDERS, 2015, 30 : S524 - S525
12345